Clinical Trial

Impact of a Simple Automated Best Practice Alert (BPA) on Quantity and Quality of In-hospital Antibiotic Use in a Tertiary and Three Secondary Hospitals

Study acronym: TARGET
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 2, 2025 (before its estimated July 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of the stepped-wedge cluster-randomized trial is to assess the impact of an antimicrobial stewardship intervention: a simple, automated Best Practice Alert (BPA) that reminds prescribers to reevaluate antibiotic therapy after 72 hours (or 24 hours for prophylaxis), in accordance with guideline recommendations. The primary hypothesis is that this simple BPA reduces antibiotic use in terms of quantity (amount and duration) and quality (spectrum breadth), measured by days of antibiotic spectrum coverage at the patient level (primary outcome), as well as at both patient and cluster levels using various metrics of antibiotic use. The trial will introduce the BPA in a stepwise manner, with all wards implementing it by the end. It will compare the intervention period to the baseline (pre-intervention) and control periods.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-08.
Status change: Not Yet Recruiting → Active, Not Recruiting 2025-08-25
Trial Details
NCT Number NCT07115966
Lead Sponsor Insel Gruppe AG, University Hospital Bern
Conditions Antibiotic Prescriptions, In-Patient Treatment
Enrollment 58 participants
Start Date 2025-08-01
Primary Completion 2026-07-31 (estimated)
Study Completion 2026-07-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-02